Results 131 to 140 of about 29,860 (191)

High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the Philippines. [PDF]

IJTLD Open
Flores I, Tujan MAA, Basilio R, Dizon TJR, Lim DR, Reyes LT, Reyes RVAG, Rojas S, Valencia AK, Capin JB, Mirtskhulava V, Palparan AG, Cabalitan C, Carpin PJ, Malbacias C, Lee JS, Gebhard A, Quelapio M, Timm J.   +18 more
europepmc   +1 more source

Epidemiological Characteristics and Treatment Outcomes of Drug-Resistant Tuberculosis in Limpopo Province, South Africa (2020-2024). [PDF]

Trop Med Infect Dis
Rukasha I, Kaapu KG.
europepmc   +1 more source

Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study. [PDF]

Lancet Microbe
Steyn J, Williams J, Naufal F, Limberis J, Grobbelaar M, Ismail N, Ghebrekristos Y, Opperman CJ, Nalyvayko A, Singh S, Colman RE, Rodwell TC, Theron G, Warren RM, Metcalfe JZ.   +14 more
europepmc   +1 more source

Clinical and Microbiological Characteristics Associated with Treatment Outcomes Among Rifampicin-Resistant Tuberculosis Patients in Limpopo Province. [PDF]

Infect Drug Resist
Rukasha I, Rakgate KA, Kaapu KG.
europepmc   +1 more source

Rising bedaquiline resistance: exploring potential causes and next steps. [PDF]

Eur Respir J
Schildkraut JA, Flood D, Sloan DJ, Heinrich N, Fox S, Lange C, Wells C, Tiberi S.   +7 more
europepmc   +1 more source

Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa. [PDF]

Clin Infect Dis
Loveday M, Clarence E, Hlangu S, Singh N, Chotoo S, Brust JCM, Waitt C, Court R, Furin J.   +8 more
europepmc   +1 more source

Bedaquiline resistance-associated genetic mutations and minimum inhibitory concentrations in drug-resistant tuberculosis clinical isolates from Limpopo province, South Africa. [PDF]

Front Microbiol
Malope P, Lekalakala-Mokaba MR, Ngcamu DC, Said H, Rukasha I, Omar SV.   +5 more
europepmc   +1 more source

Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens. [PDF]

Open Forum Infect Dis
Moreira A, Hassneiah D, Beekmann SE, Polgreen P, Shah M, Nathavitharana RR.   +5 more
europepmc   +1 more source

Current and emerging therapies for pulmonary tuberculosis in adults. [PDF]

BMJ Med
Mahmood A, Ashfaq MB, Drain C, Melby E, Hunter M, Shaw TD.   +5 more
europepmc   +1 more source

Bedaquiline Resistance in Drug-Resistant Tuberculosis in South Africa: A Systematic Review and Meta-Analysis of Emerging Trends. [PDF]

Antibiotics (Basel)
Kaapu KG, Makondo VT, Costa Conceição E, Rukasha I.   +3 more
europepmc   +1 more source